Literature DB >> 14513407

Novel mutations involving the NF1 gene coding sequence in neurofibromatosis type 1 patients from Taiwan.

Ming-Tzen Liu1,2, Jih-Shyun Su3, Chun-Yu Huang2, Shih-Feng Tsai4,5.   

Abstract

Neurofibromatosis type 1 (NF1) is a common cancer predisposition syndrome affecting the nervous system. The disease is one of the most common autosomal dominant diseases in all ethnic groups. Although the gene was mapped to human chromosome 17 and isolated in 1990, the detection of NF1 mutation is still considered to be a challenge as the gene is large and contains multiple exons. Here we report the detection of three genomic mutations in three Chinese patients living in Taiwan. A DNA diagnosis procedure was established to investigate the NF1 gene mutation at both the transcript and genomic DNA levels. Mutations causing transcript alteration were uncovered in three patients. In the first case, we detected a deletion involving exons 39-45 (nucleotide 7260-8167 in GenBank accession No. M89914). In the second case, a 2199-2448 deletion resulted in skipping of exon 13. The third case skipped the exon 3 in the mutant transcript. We further investigated what caused the cDNA deletion by PCR using genomic DNA as a template. In the first patient, we identified an approximately 17.5 kbp deletion in the NF1 gene. In the other two patients, we identified a single-base substitution (IVS13+1G>A) at the splicing donor site in the second case, and an IVS3+1G>T substitution in the third case. We conclude that genomic deletion and alteration of splicing signal caused abnormal transcripts and truncated proteins in the three Taiwanese NF1 cases.

Entities:  

Mesh:

Year:  2003        PMID: 14513407     DOI: 10.1007/s10038-003-0066-7

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  6 in total

1.  Neurofibromatosis 1

Authors: 
Journal:  Am J Med Genet       Date:  1999-03-26

2.  Aberrant regulation of ras proteins in malignant tumour cells from type 1 neurofibromatosis patients.

Authors:  T N Basu; D H Gutmann; J A Fletcher; T W Glover; F S Collins; J Downward
Journal:  Nature       Date:  1992-04-23       Impact factor: 49.962

3.  cDNA cloning of the type 1 neurofibromatosis gene: complete sequence of the NF1 gene product.

Authors:  D A Marchuk; A M Saulino; R Tavakkol; M Swaroop; M R Wallace; L B Andersen; A L Mitchell; D H Gutmann; M Boguski; F S Collins
Journal:  Genomics       Date:  1991-12       Impact factor: 5.736

Review 4.  Molecular genetics of neurofibromatosis type 1 (NF1).

Authors:  M H Shen; P S Harper; M Upadhyaya
Journal:  J Med Genet       Date:  1996-01       Impact factor: 6.318

5.  Minor lesion mutational spectrum of the entire NF1 gene does not explain its high mutability but points to a functional domain upstream of the GAP-related domain.

Authors:  R Fahsold; S Hoffmeyer; C Mischung; C Gille; C Ehlers; N Kücükceylan; M Abdel-Nour; A Gewies; H Peters; D Kaufmann; A Buske; S Tinschert; P Nürnberg
Journal:  Am J Hum Genet       Date:  2000-03       Impact factor: 11.025

6.  Distribution of 13 truncating mutations in the neurofibromatosis 1 gene.

Authors:  R A Heim; L N Kam-Morgan; C G Binnie; D D Corns; M C Cayouette; R A Farber; A S Aylsworth; L M Silverman; M C Luce
Journal:  Hum Mol Genet       Date:  1995-06       Impact factor: 6.150

  6 in total
  1 in total

1.  Breakpoint characterization of a novel NF1 multiexonic deletion: a case showing expression of the mutated allele.

Authors:  Francesca Orzan; Michela Stroppi; Marco Venturin; M Carmen Valero; Concepcion Hernández; Paola Riva
Journal:  Neurogenetics       Date:  2008-01-10       Impact factor: 2.660

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.